ClinicalTrials.Veeva

Menu

3D Printed Oral Stents for Patients with Head and Neck Cancer Receiving Radiation Therapy

M.D. Anderson Cancer Center logo

M.D. Anderson Cancer Center

Status

Terminated

Conditions

Malignant Head and Neck Neoplasm

Treatments

Other: Questionnaire Administration
Device: Stent Device

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05126797
2017-0269 (Other Identifier)
NCI-2019-02460 (Registry Identifier)

Details and patient eligibility

About

This trial studies how a customized 3D-printed oral stent compares to a standard stent made by a dentist for use in imaging scans in patients with head and neck cancer receiving radiation therapy. Oral stents are designed to help prevent radiation-related side effects while receiving radiation therapy. Traditional oral stents are created by dentists, require at least 2 separate appointments, and may not be as cost-effective. A customized, 3D-printed oral stent may perform as well as a standard stent made by a dentist and have a significantly shorter turnaround to device delivery.

Full description

PRIMARY OBJECTIVES:

I. To evaluate whether a customized 3 dimensional (3D) printed oral stent achieves non-inferior levels of patient reported outcomes as the standard dental-fabricated oral stents at the time prior to starting treatment.

SECONDARY OBJECTIVES:

I. To evaluate the performance of the 3D stent on imaging parameters (i.e. mandibular and soft tissue displacement) for degree of normal tissue sparing.

II. Evaluate the levels of patient reported outcomes after patients have developed side effects from radiation treatment.

III. To evaluate the commercially available TruGuard oral cavity positioning system.

OUTLINE:

Patients wear a customized 3D printed oral stent over 5-10 minutes in the supine position at the time of radiation simulation, before starting radiation therapy, and in the 3rd to 5th week of radiation therapy. Patients may also optionally wear the commercially-made stent called TruGuard at these timepoints.

Enrollment

57 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient is dispositioned to receive definitive or adjuvant radiotherapy for treatment of a diagnosed head and neck malignancy.
  • Treating radiation oncologist has determined the necessity of an oral stent and a device has been fabricated by dentistry at MD Anderson Cancer Center (MDACC).
  • Patient has received pre-treatment imaging which includes the mandibular and maxillary dentition.
  • Eastern Cooperative Oncology Group performance status (ECOG PS) 0-2.
  • Signed study-specific consent form.

Exclusion criteria

  • No pre-treatment computed tomography (CT) imaging including the maxilla and mandible is available.
  • Prior head and neck radiotherapy.
  • Severe trismus with an incisal opening of < 10 mm.
  • Inability to comply with the study procedures.
  • Patients who have received dental stents fabricated outside of MDACC.

Trial design

Primary purpose

Device Feasibility

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

57 participants in 1 patient group

3D printed stent+ MDASI-3D Oral Stents Questionnaire
Other group
Description:
Patients wear a customized 3D printed oral stent over 5-10 minutes in the supine position at the time of radiation simulation, before starting radiation therapy, and in the 3rd to 5th week of radiation therapy. Patients may also optionally wear the commercially-made stent called TruGuard at these timepoints. Ancillary Studies (MDASI-3D Oral Stents Questionnaire)
Treatment:
Device: Stent Device
Other: Questionnaire Administration

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems